| (CB1)/(CB2) | cannabinoid receptor 1 and receptor2 |
| (ceRNA) | competing endogenous RNA |
| (CMA) | chaperon-mediated autophagy |
| (HCQ) | hydroxychloroquine |
| (HIF-1a) | hypoxia-inducible factor-1 |
| (HMGB1) | high-mobility group box 1 |
| (LAMP-2A) | lysosomal membrane protein 2A |
| (lncRNA) | long noncoding RNA |
| (microRNAs) | small non-coding RNA molecules |
| (MSI-H) | microsatellite instability |
| (mTOR) | mechanistic target of rapamycin |
| (PADC) | pancreatic adenocarcinoma |
| (PE) | lipid phosphatidylethanolamine |
| (PVT1) | plasmacytoma variant translocation 1 |
| (Pygo2) | pygopus2 |
| (RAGE) | receptors for advanced glycation end products |
| (ROS) | reactive oxygen species |
| (siRNA) | small interfering RNA |
| (TME) | tumor microenvironment |
| (UA) | ursolic acid |
| (ULK1) | Unc-51-like kinase1 complex |
| (VMP1) | vacuole membrane protein 1 |